To Evaluate HU-045 in the Treatment of Glabellar Lines(Phase III)
To Evaluate HU-045 in the Treatment of Glabellar Lines(Phase III)
Recruiting · NCT06205797 · Registry updated 2024-10-03Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| To Evaluate HU-045 in the Treatment of Glabellar Lines(Phase III) | Glabellar Lines | Recruiting | Phase 3 | 2024-10-03 | NCT06205797 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Huons Biopharma | 1 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Kangbuk Samsung Hospital | Seoul | South Korea | 24 |